Correction: BRAF Testing in Melanoma and Colorectal Cancer in Latin America: Challenges and Opportunities

Affiliations

¹ Medical Oncology, Centro Paulista de Oncologia, Sao Paulo, BRA.
² Anatomical Pathology, Hospital Rafael Angel Calderón Guardia, San Jose, CRI.
³ Oncological Center, Médica Sur, Mexico City, MEX.
⁴ Pathology, Hospital Italiano de Buenos Aires, Buenos Aires, ARG.
⁵ Pathology, Institute of Translational Medicine and Biomedical Engineering (IMTIB), Buenos Aires, ARG.
⁶ Genetics, Americas Health Foundation, Laguna Beach, USA.
⁷ Pathology, Instituto Nacional de Cancerología, Bogota, COL.
⁸ Caja Costarricense de Seguro Social, Hospital San Juan de Dios, San José, CRI.
⁹ Health Technology Assessment, Unimed, Porto Alegre, BRA.

Published Erratum

Renata D Peixoto et al. Cureus. 2022.

. 2022 Dec 2;14(12):c83.

doi: 10.7759/cureus.c83. eCollection 2022 Dec.

¹ Medical Oncology, Centro Paulista de Oncologia, Sao Paulo, BRA.
² Anatomical Pathology, Hospital Rafael Angel Calderón Guardia, San Jose, CRI.
³ Oncological Center, Médica Sur, Mexico City, MEX.
⁴ Pathology, Hospital Italiano de Buenos Aires, Buenos Aires, ARG.
⁵ Pathology, Institute of Translational Medicine and Biomedical Engineering (IMTIB), Buenos Aires, ARG.
⁶ Genetics, Americas Health Foundation, Laguna Beach, USA.
⁷ Pathology, Instituto Nacional de Cancerología, Bogota, COL.
⁸ Caja Costarricense de Seguro Social, Hospital San Juan de Dios, San José, CRI.
⁹ Health Technology Assessment, Unimed, Porto Alegre, BRA.

Abstract

[This corrects the article DOI: 10.7759/cureus.31972.].

No competing interests declared.

BRAF Testing in Melanoma and Colorectal Cancer in Latin America: Challenges and Opportunities.
Peixoto RD, Chakhtoura JJA, Aguilar-Ponce JL, Garcia-Rivello H, Jansen AM, Parra Medina R, Ramos-Esquivel A, Stefani SD. Peixoto RD, et al. Cureus. 2022 Nov 28;14(11):e31972. doi: 10.7759/cureus.31972. eCollection 2022 Nov. Cureus. 2022. PMID: 36589179 Free PMC article. Review.